MS Drug Marketers Don't Give a Damn About Patients | Pharmaguy's Insights Into Drug Industry News |

KEY TAKEAWAY: American medicine is heading into new terrain, a place where a year’s supply of drugs can come with a price tag that exceeds what an average family earns.  Pharmacy benefit manager Express Scripts says lastyear more than half a million Americans racked up prescription drug bills exceeding $50,000.

If you read the press releases from ASCO you can plainly see that drug companies were trying to play up to Wall Street not doctors.  I don’t believe that you can serve both Wall Street and patients because the street is only interested in financial performance and today that means very expensive drugs.

MS patients have very special needs to help them navigate and get much needed drugs but as the article on NPR indicates these drugs come at a very steep price.  Bayer does a great job helping patients get the drugs they need, but Biogen’s patient help line was of very little use to an MS patient I know and in fact she said that the difficulties with their patient support line made her feel like “they didn’t give a damn about anything other than sales”.